73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers reveal key to targeting dormant cancer cells

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team
What is a mammogram, and why are they important?

What is a mammogram, and why are they important?

by Laurel KellyCredit: Pixabay/CC0 Public DomainBreast cancer accounts for 1 in 3 of all new cancers diagnosed in women in the U.S. each year, according to the American Cancer Society. It's estima

What is a mammogram, and why are they important?

by Laurel KellyCredit: Pixabay/CC0 Public DomainBreast cancer accounts for 1 in 3 of all new cancers diagnosed in women in the U.S. each year, according to the American Cancer Society. It's estima
In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out
Trial shows promise for new antibody cancer treatment

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new

Trial shows promise for new antibody cancer treatment

byKing's College LondonMechanism of cytotoxicity mediated by MOv18 IgE. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-39679-9The first ever clinical trial of a new
Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre
Researchers ID risks for second childhood cancers

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou
Study: Vitamin D may play a role in prostate cancer disparities

Study: Vitamin D may play a role in prostate cancer disparities

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainVitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with Euro

Study: Vitamin D may play a role in prostate cancer disparities

by Cedars-Sinai Medical CenterCredit: CC0 Public DomainVitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with Euro
Researchers identify barriers to breast cancer screening in vulnerable populations

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to
Review paper compares two leading pancreatic cancer drugs

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi
Negative fecal tests tied to low risk for advanced colorectal cancer

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis